Martingale Asset Management L P Acquires Shares of 2,804 HealthEquity, Inc. $HQY

Key Points

• Martingale Asset Management L P acquired 2,804 shares of HealthEquity, Inc. (NASDAQ: HQY), valued at approximately $248,000, as reported in their recent SEC filing.
• Analysts have shown strong confidence in HealthEquity, with multiple upgrades, raising the target price from a range of $94.00 to $125.00, and a consensus rating of "Buy".
• HealthEquity reported earnings of $0.97 per share for the latest quarter, exceeding expectations and setting FY 2026 guidance at 3.610-3.78 EPS.

Martingale Asset Management L P acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,804 shares of the company's stock, valued at approximately $248,000.

Several other institutional investors and hedge funds have also bought and sold shares of HQY. Invesco Ltd. grew its holdings in HealthEquity by 50.6% during the first quarter. Invesco Ltd. now owns 2,446,198 shares of the company's stock valued at $216,171,000 after purchasing an additional 821,425 shares during the period. Nuveen LLC bought a new position in HealthEquity during the first quarter valued at $53,076,000. Westfield Capital Management Co. LP bought a new position in HealthEquity during the first quarter valued at $49,787,000. Premier Fund Managers Ltd grew its holdings in HealthEquity by 3,601.6% during the first quarter. Premier Fund Managers Ltd now owns 409,992 shares of the company's stock valued at $35,610,000 after purchasing an additional 398,916 shares during the period. Finally, Iron Triangle Partners LP bought a new position in HealthEquity during the fourth quarter valued at $32,202,000. 99.55% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on HQY. Royal Bank Of Canada increased their target price on HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 4th. JMP Securities boosted their price objective on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research note on Wednesday, June 4th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday, June 6th. Barrington Research boosted their price objective on HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a research note on Thursday, June 5th. Finally, The Goldman Sachs Group boosted their price objective on HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a research note on Wednesday, June 4th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, HealthEquity presently has a consensus rating of "Buy" and an average target price of $118.55.

HealthEquity Price Performance

NASDAQ:HQY opened at $89.33 on Wednesday. The firm has a market capitalization of $7.72 billion, a price-to-earnings ratio of 65.20, a P/E/G ratio of 1.35 and a beta of 0.54. HealthEquity, Inc. has a 52-week low of $73.84 and a 52-week high of $116.65. The stock has a fifty day moving average of $96.29 and a 200 day moving average of $96.21. The company has a debt-to-equity ratio of 0.50, a quick ratio of 4.06 and a current ratio of 4.06.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.During the same quarter last year, the company earned $0.80 earnings per share. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. On average, research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Activity at HealthEquity

In related news, Director Jon Kessler sold 97,767 shares of HealthEquity stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.05, for a total transaction of $10,954,792.35. Following the completion of the sale, the director owned 75,000 shares of the company's stock, valued at approximately $8,403,750. This trade represents a 56.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction on Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares of the company's stock, valued at $5,414,579.25. This represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 291,744 shares of company stock valued at $32,705,007. Company insiders own 1.50% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.